欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
Tazemetostat hydrobromide_1467052-75-0_产品详情
1467052-75-0
  • Tazemetostat hydrobromide

  • names:

    Tazemetostat hydrobromide

  • CAS号:

    1467052-75-0

    MDL Number:
  • MF(分子式): C34H45BrN4O4 MW(分子量): 653.65
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
Tazemetostat hydrobromide
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM003070-10mg 10mg 99.18% ¥ 2835.00 ¥ 2835.00 2-3天
- +
¥ 0.00
YZM003070-5mg 5mg 99.18% ¥ 780.00 ¥ 780.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 1467052-75-0
Inchi
InchiKey
分子式 Formula C34H45BrN4O4
分子量 Molecular Weight 653.65
溶解度Solubility 生物体外In Vitro:DMSO溶解度100 mg/mL(152.99 mM;Need ultrasonic)
性状
储藏条件 Storage conditions 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月
Tazemetostat hydrobromide(CAS:1467052-75-0)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 Tazemetostat hydrobromide (EPZ-6438 hydrobromide) 是一种有效的,选择性,口服的EZH2抑制剂
IntroductionTazemetostat hydrobromide (EPZ438 hydrobromide) is a potent, selective and orally availableEZH2inhibitor. Tazemetostat hydrobromide inhibits the activity of human polycomb repressive complex 2 (PRC2)ontaining wildype EZH2 with aKivalue of 2.5 nM. Tazemetostat hydrobromide inhibits EZH2 with IC50s of 11 and 16 nM in peptide assay and nucleosome assay, respectively. Tazemetostat hydrobromide inhibits Rat EZH2 with an IC50of 4 nM. Tazemetostat hydrobromide also inhibits EZH1 with an IC50of 392 nM.
Application1
Application2
Application3
Tazemetostat hydrobromide (EPZ-6438 hydrobromide) 是一种有效的,选择性,口服的EZH2抑制剂。Tazemetostat hydrobromide 抑制含有 PRC2 复合体的野生型 EZH2 的活性,Ki值为 2.5±0.5 nM。Tazemetostat hydrobromide 抑制 EZH2,在肽测定和核小体测定中 IC50分别为 11 和 16 nM。Tazemetostat hydrobromide 抑制大鼠 EZH2,IC50为 4 nM。Tazemetostat hydrobromide 还抑制 EZH1,IC50为 392 nM。Tazemetostat hydrobromide (EPZ-6438 hydrobromide) is a potent, selective and orally availableEZH2inhibitor. Tazemetostat hydrobromide inhibits the activity of human polycomb repressive complex 2 (PRC2)-containing wild-type EZH2 with aKivalue of 2.5 nM. Tazemetostat hydrobromide inhibits EZH2 with IC50s of 11 and 16 nM in peptide assay and nucleosome assay, respectively. Tazemetostat hydrobromide inhibits Rat EZH2 with an IC50of 4 nM. Tazemetostat hydrobromide also inhibits EZH1 with an IC50of 392 nM.
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Knutson SK, et al. Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferaseEZH2. Proc Natl Acad Sci U S A. 2013 May 7;110(19):7922-7.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents